From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.  They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations.  Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Investment Management

OrbiMed

Managing Partners

Jonathan T. Silverstein

Carl L. Gordon

Sven H. Borho

Rishi Gupta

Peter Thompson

Erez Chimovits

Matthew S. Rizzo

William F. Sawyer

Mona Ashiya

Steven D. Wang

David Wang

Trevor M. Polischuk

Iris Wang

W. Carter Neild

C. Scotland Stevens

Geoffrey C. Hsu

David Bonita

Leadership Team

Partners

General Partners

Teams at OrbiMed

Leadership Team

Partners

General Partners